Medicine Recommendations
To view Article Recommendations, you must have an active subscription.
If your access has expired, you can subscribe at $9.95 per month, the first month of your subscription will be free of charge.
If you think you should be able to access this content, please contact us.
Sign in | Subscribe | Recommend to Library
New to F1000? See this week’s top article below for a free preview of a Recommendation.
LATEST RECOMMENDATION
Daniel Indelicato, Shands Cancer Hospital at the University of Florida, USA. F1000 Oncology
TOP RATED ARTICLE THIS WEEK [FREE TO VIEW]
7 Recommendations, most recent by
Dominique Ferrandon, Institut de Biologie Moléculaire et Cellulaire du CNRS, France. F1000 Immunology
- Good for Teaching
- New Finding
- Technical Advance
Past 7 Days
468
New Recommendations
107,037 total
180
New Articles Recommended
38,695 total
Past 30 Days
-
174Articles Classified As Controversial8,014 total
-
77Articles Classified As Novel Drug Target1,671 total
-
9Articles Classified As Changes Clinical Practice3,958 total
-
95Articles Classified As Review / Commentary5,611 total
-
354Articles Classified As Confirmation27,044 total
-
98Articles Classified As Technical Advance7,031 total
-
761Articles Classified As New Finding50,384 total
-
209Articles Classified As Interesting Hypothesis14,429 total
-
353Articles Classified As Good for Teaching3,429 total
-
24Articles Classified As Refutation1,608 total
-
559Articles Classified As Clinical Trial27,520 total
INDIVIDUAL SUBSCRIPTIONS
Get instant access to Article Recommendations from more than 5,000 expert scientists and clinical researchers, assisted by 5,000 associates, by taking out a monthly subscription. The first month of your subscription will be free of charge.
Start your personal subscription today.
Subscribe for $9.95/monthINSTITUTIONAL SUBSCRIPTIONS
Send a recommendation to your institution's librarian or information manager to request an extended free trial for all users.
Recommend to your LibrarianIf you are a librarian or information manager, you may request an extended free trial for your academic or corporate institution.
Request an Institutional Trialyour institution might be eligible for free access via our sponsorship scheme. Check our sponsorship page.
